Concepedia

Shinsuke Ooike

SO

3

Publications

118

Citations

3

H-Index

2010

Active since

Affiliations

Mitsubishi Tanabe Pharma Corporation(Current)

Mitsubishi Chemical (Japan)

Shinsuke Ooike is an author at Mitsubishi Tanabe Pharma Corporation specializing in drug discovery, medicinal chemistry, and medicine.

Top concepts

MedicinePharmacologyDrug DiscoveryMedicinal ChemistryImmunologyCell BiologyTumor BiologyCancer BiologyPharmacotherapyDrug Development

Publications per year

2010–2016

3

Publications

3

Abstract C244: Development of the BET bromodomain inhibitor OTX015.

J. Kay Noel, Kazunori Iwata, Shinsuke Ooike et al. · Molecular Cancer Therapeutics · 2013 · 80 citations

Medicinal Chemistry, Bet Bromodomain Proteins, Novel Therapy +15

3-Cyano-6-(5-methyl-3-pyrazoloamino)pyridines: Selective Aurora A kinase inhibitors

Ryoichi Ando, Hiroshi Ikegami, Makoto Sakiyama et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 26 citations · Full text

Medicinal Chemistry, Medicine, Anti-cancer Agent +4

A phenotypic drug discovery study on thienodiazepine derivatives as inhibitors of T cell proliferation induced by CD28 co-stimulation leads to the discovery of a first bromodomain inhibitor

Junichi Endo, Hidemasa Hikawa, Maiko Hamada et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 12 citations · Full text

Medicinal Chemistry, Immunology, Pharmacology +8

Rows per page

1–3 of 3